Compare, Analyse Aurobindo Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

AUROBINDO PHARMA     Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AUROBINDO PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-19
ADCOCK INGRAM
Jun-14
AUROBINDO PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs830383-   
Low Rs527276-   
Sales per share (Unadj.) Rs333.9113.9-  
Earnings per share (Unadj.) Rs40.4-28.7-  
Cash flow per share (Unadj.) Rs51.8-23.8-  
Dividends per share (Unadj.) Rs2.500-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs237.189.4-  
Shares outstanding (eoy) m585.91168.78-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.02.9 70.2%   
Avg P/E ratio x16.8-11.5 -146.4%  
P/CF ratio (eoy) x13.1-13.9 -94.6%  
Price / Book Value ratio x2.93.7 77.6%  
Dividend payout %6.20-   
Avg Mkt Cap Rs m397,56955,608 714.9%   
No. of employees `00017.94.3 415.9%   
Total wages/salary Rs m25,8493,490 740.6%   
Avg. sales/employee Rs Th10,956.94,476.9 244.7%   
Avg. wages/employee Rs Th1,447.7813.0 178.1%   
Avg. net profit/employee Rs Th1,324.3-1,128.1 -117.4%   
INCOME DATA
Net Sales Rs m195,63619,219 1,017.9%  
Other income Rs m1,553135 1,154.0%   
Total revenues Rs m197,18919,354 1,018.9%   
Gross profit Rs m39,519-3,331 -1,186.6%  
Depreciation Rs m6,680829 805.3%   
Interest Rs m2,626521 504.4%   
Profit before tax Rs m31,767-4,546 -698.8%   
Minority Interest Rs m27-13 -213.1%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-8810-   
Tax Rs m7,269284 2,558.8%   
Profit after tax Rs m23,645-4,843 -488.2%  
Gross profit margin %20.2-17.3 -116.6%  
Effective tax rate %22.9-6.2 -366.2%   
Net profit margin %12.1-25.2 -48.0%  
BALANCE SHEET DATA
Current assets Rs m153,64514,076 1,091.5%   
Current liabilities Rs m120,4297,920 1,520.6%   
Net working cap to sales %17.032.0 53.0%  
Current ratio x1.31.8 71.8%  
Inventory Days Days135111 121.9%  
Debtors Days Days64124 51.4%  
Net fixed assets Rs m103,9098,205 1,266.4%   
Share capital Rs m58689 656.6%   
"Free" reserves Rs m138,3220-   
Net worth Rs m138,90815,085 920.8%   
Long term debt Rs m1,8005,301 33.9%   
Total assets Rs m264,54428,497 928.3%  
Interest coverage x13.1-7.7 -169.4%   
Debt to equity ratio x00.4 3.7%  
Sales to assets ratio x0.70.7 109.7%   
Return on assets %9.9-15.2 -65.5%  
Return on equity %17.0-32.1 -53.0%  
Return on capital %23.8-19.8 -120.3%  
Exports to sales %49.60-   
Imports to sales %18.80-   
Net fx Rs m56,7270-   
CASH FLOW
From Operations Rs m16,2201,640 988.7%  
From Investments Rs m-28,768-504 5,711.3%  
From Financial Activity Rs m19,1914,811 398.9%  
Net Cashflow Rs m6,6565,948 111.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.28 Rs / ZAR

Compare AUROBINDO PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare AUROBINDO PHARMA With: JUBILANT PHARMOVA   ELDER PHARMA  ALEMBIC PHARMA  GSK PHARMA  NOVARTIS  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views On News

AUROBINDO PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 25.6% (Quarterly Result Update)

Sep 15, 2020 | Updated on Sep 15, 2020

For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)

Jun 5, 2020 | Updated on Jun 5, 2020

For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Nov 6, 2019 | Updated on Nov 6, 2019

Here's an analysis of the annual report of AUROBINDO PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

An India Revival Stock I'm Bullish On... (Profit Hunter)

Apr 9, 2021

This could take India to the position of 3rd largest economy.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

Why the Market Fell Yesterday (Fast Profits Daily)

Apr 6, 2021

In this video, I'll tell you the two reasons why the market fell on Monday and how you can prepare yourself for such events in the future.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

AUROBINDO PHARMA SHARE PRICE


Apr 16, 2021 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA - SUVEN LIFE SCIENCES COMPARISON

COMPARE AUROBINDO PHARMA WITH

FEATURED VIDEOS

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

Nifty: Bear Trap?

More Featured Videos

MARKET STATS